Wize Pharma

Wize Pharma CapEx/OCF

Delisted·Jan 10, 2019

The CapEx to Operating Cash Flow Ratio of Wize Pharma (WIZP) as of Nov 19, 2026 is -0.07 %.

CapEx/OCF

-0.07 %

Last updated:

CapEx to Operating Cash Flow Ratio of Wize Pharma is 2020 -0.07 % . CapEx to Operating Cash Flow Ratio of Wize Pharma was 2019 0.00 . It decreases by % lower compared to the previous year.

The Wize Pharma CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2014
-6.67 USD
Jan 1, 2015
-0.36 USD
Jan 1, 2016
-0.11 USD
Jan 1, 2017
-0.29 USD
Jan 1, 2018
-0.23 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
-0.07 USD
The Wize Pharma CapEx/OCF history
YEARCapEx/OCFYoY
-0.07 %—
0.00-100.00%
-0.23 %-22.78%
-0.29 %+156.30%
-0.11 %-67.91%
-0.36 %-94.65%
-6.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

CapEx to Operating Cash Flow Ratio of Wize Pharma is -0.07 % in 2020.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Wize Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Wize Pharma

All Key Metrics — Wize Pharma